Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Recombinant Protein Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Hormones
1.2.3 Blood Clotting Factors
1.2.4 Cytokines
1.2.5 Enzymes
1.2.6 Fusion Proteins
1.2.7 Others
1.3 Market by Application
1.3.1 Global Therapeutic Recombinant Protein Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical Company
1.3.3 Research Institute
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Recombinant Protein Market Perspective (2018-2033)
2.2 Therapeutic Recombinant Protein Growth Trends by Region
2.2.1 Global Therapeutic Recombinant Protein Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Therapeutic Recombinant Protein Historic Market Size by Region (2018-2023)
2.2.3 Therapeutic Recombinant Protein Forecasted Market Size by Region (2024-2033)
2.3 Therapeutic Recombinant Protein Market Dynamics
2.3.1 Therapeutic Recombinant Protein Industry Trends
2.3.2 Therapeutic Recombinant Protein Market Drivers
2.3.3 Therapeutic Recombinant Protein Market Challenges
2.3.4 Therapeutic Recombinant Protein Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Recombinant Protein Players by Revenue
3.1.1 Global Top Therapeutic Recombinant Protein Players by Revenue (2018-2023)
3.1.2 Global Therapeutic Recombinant Protein Revenue Market Share by Players (2018-2023)
3.2 Global Therapeutic Recombinant Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Therapeutic Recombinant Protein Revenue
3.4 Global Therapeutic Recombinant Protein Market Concentration Ratio
3.4.1 Global Therapeutic Recombinant Protein Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Recombinant Protein Revenue in 2022
3.5 Therapeutic Recombinant Protein Key Players Head office and Area Served
3.6 Key Players Therapeutic Recombinant Protein Product Solution and Service
3.7 Date of Enter into Therapeutic Recombinant Protein Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Recombinant Protein Breakdown Data by Type
4.1 Global Therapeutic Recombinant Protein Historic Market Size by Type (2018-2023)
4.2 Global Therapeutic Recombinant Protein Forecasted Market Size by Type (2024-2033)
5 Therapeutic Recombinant Protein Breakdown Data by Application
5.1 Global Therapeutic Recombinant Protein Historic Market Size by Application (2018-2023)
5.2 Global Therapeutic Recombinant Protein Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Therapeutic Recombinant Protein Market Size (2018-2033)
6.2 North America Therapeutic Recombinant Protein Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Therapeutic Recombinant Protein Market Size by Country (2018-2023)
6.4 North America Therapeutic Recombinant Protein Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Therapeutic Recombinant Protein Market Size (2018-2033)
7.2 Europe Therapeutic Recombinant Protein Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Therapeutic Recombinant Protein Market Size by Country (2018-2023)
7.4 Europe Therapeutic Recombinant Protein Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Recombinant Protein Market Size (2018-2033)
8.2 Asia-Pacific Therapeutic Recombinant Protein Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Therapeutic Recombinant Protein Market Size by Region (2018-2023)
8.4 Asia-Pacific Therapeutic Recombinant Protein Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Therapeutic Recombinant Protein Market Size (2018-2033)
9.2 Latin America Therapeutic Recombinant Protein Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Therapeutic Recombinant Protein Market Size by Country (2018-2023)
9.4 Latin America Therapeutic Recombinant Protein Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Recombinant Protein Market Size (2018-2033)
10.2 Middle East & Africa Therapeutic Recombinant Protein Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Therapeutic Recombinant Protein Market Size by Country (2018-2023)
10.4 Middle East & Africa Therapeutic Recombinant Protein Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Detail
11.1.2 Abcam Business Overview
11.1.3 Abcam Therapeutic Recombinant Protein Introduction
11.1.4 Abcam Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.1.5 Abcam Recent Development
11.2 HALIX
11.2.1 HALIX Company Detail
11.2.2 HALIX Business Overview
11.2.3 HALIX Therapeutic Recombinant Protein Introduction
11.2.4 HALIX Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.2.5 HALIX Recent Development
11.3 Avantor
11.3.1 Avantor Company Detail
11.3.2 Avantor Business Overview
11.3.3 Avantor Therapeutic Recombinant Protein Introduction
11.3.4 Avantor Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.3.5 Avantor Recent Development
11.4 Miltenyi Biotec
11.4.1 Miltenyi Biotec Company Detail
11.4.2 Miltenyi Biotec Business Overview
11.4.3 Miltenyi Biotec Therapeutic Recombinant Protein Introduction
11.4.4 Miltenyi Biotec Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.4.5 Miltenyi Biotec Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Therapeutic Recombinant Protein Introduction
11.5.4 Thermo Fisher Scientific Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Bio-Techne Corporation
11.6.1 Bio-Techne Corporation Company Detail
11.6.2 Bio-Techne Corporation Business Overview
11.6.3 Bio-Techne Corporation Therapeutic Recombinant Protein Introduction
11.6.4 Bio-Techne Corporation Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.6.5 Bio-Techne Corporation Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Therapeutic Recombinant Protein Introduction
11.7.4 Merck Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.7.5 Merck Recent Development
11.8 ACROBiosystems
11.8.1 ACROBiosystems Company Detail
11.8.2 ACROBiosystems Business Overview
11.8.3 ACROBiosystems Therapeutic Recombinant Protein Introduction
11.8.4 ACROBiosystems Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.8.5 ACROBiosystems Recent Development
11.9 Abnova
11.9.1 Abnova Company Detail
11.9.2 Abnova Business Overview
11.9.3 Abnova Therapeutic Recombinant Protein Introduction
11.9.4 Abnova Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.9.5 Abnova Recent Development
11.10 Eurogentec (Kaneka Corporation)
11.10.1 Eurogentec (Kaneka Corporation) Company Detail
11.10.2 Eurogentec (Kaneka Corporation) Business Overview
11.10.3 Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Introduction
11.10.4 Eurogentec (Kaneka Corporation) Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.10.5 Eurogentec (Kaneka Corporation) Recent Development
11.11 Cytiva (Danaher )
11.11.1 Cytiva (Danaher ) Company Detail
11.11.2 Cytiva (Danaher ) Business Overview
11.11.3 Cytiva (Danaher ) Therapeutic Recombinant Protein Introduction
11.11.4 Cytiva (Danaher ) Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.11.5 Cytiva (Danaher ) Recent Development
11.12 Reprocell
11.12.1 Reprocell Company Detail
11.12.2 Reprocell Business Overview
11.12.3 Reprocell Therapeutic Recombinant Protein Introduction
11.12.4 Reprocell Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.12.5 Reprocell Recent Development
11.13 GenScript
11.13.1 GenScript Company Detail
11.13.2 GenScript Business Overview
11.13.3 GenScript Therapeutic Recombinant Protein Introduction
11.13.4 GenScript Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.13.5 GenScript Recent Development
11.14 BPS Bioscience
11.14.1 BPS Bioscience Company Detail
11.14.2 BPS Bioscience Business Overview
11.14.3 BPS Bioscience Therapeutic Recombinant Protein Introduction
11.14.4 BPS Bioscience Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.14.5 BPS Bioscience Recent Development
11.15 Sino Biological
11.15.1 Sino Biological Company Detail
11.15.2 Sino Biological Business Overview
11.15.3 Sino Biological Therapeutic Recombinant Protein Introduction
11.15.4 Sino Biological Revenue in Therapeutic Recombinant Protein Business (2018-2023)
11.15.5 Sino Biological Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Therapeutic Recombinant Protein Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Hormones
Table 3. Key Players of Blood Clotting Factors
Table 4. Key Players of Cytokines
Table 5. Key Players of Enzymes
Table 6. Key Players of Fusion Proteins
Table 7. Key Players of Others
Table 8. Global Therapeutic Recombinant Protein Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Therapeutic Recombinant Protein Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Therapeutic Recombinant Protein Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Therapeutic Recombinant Protein Market Share by Region (2018-2023)
Table 12. Global Therapeutic Recombinant Protein Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Therapeutic Recombinant Protein Market Share by Region (2024-2033)
Table 14. Therapeutic Recombinant Protein Market Trends
Table 15. Therapeutic Recombinant Protein Market Drivers
Table 16. Therapeutic Recombinant Protein Market Challenges
Table 17. Therapeutic Recombinant Protein Market Restraints
Table 18. Global Therapeutic Recombinant Protein Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Therapeutic Recombinant Protein Market Share by Players (2018-2023)
Table 20. Global Top Therapeutic Recombinant Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Recombinant Protein as of 2022)
Table 21. Ranking of Global Top Therapeutic Recombinant Protein Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Therapeutic Recombinant Protein Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Therapeutic Recombinant Protein Product Solution and Service
Table 25. Date of Enter into Therapeutic Recombinant Protein Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Therapeutic Recombinant Protein Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Therapeutic Recombinant Protein Revenue Market Share by Type (2018-2023)
Table 29. Global Therapeutic Recombinant Protein Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Therapeutic Recombinant Protein Revenue Market Share by Type (2024-2033)
Table 31. Global Therapeutic Recombinant Protein Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Therapeutic Recombinant Protein Revenue Market Share by Application (2018-2023)
Table 33. Global Therapeutic Recombinant Protein Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Therapeutic Recombinant Protein Revenue Market Share by Application (2024-2033)
Table 35. North America Therapeutic Recombinant Protein Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Therapeutic Recombinant Protein Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Therapeutic Recombinant Protein Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Therapeutic Recombinant Protein Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe Therapeutic Recombinant Protein Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Therapeutic Recombinant Protein Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Therapeutic Recombinant Protein Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific Therapeutic Recombinant Protein Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Therapeutic Recombinant Protein Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Therapeutic Recombinant Protein Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America Therapeutic Recombinant Protein Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Therapeutic Recombinant Protein Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Therapeutic Recombinant Protein Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa Therapeutic Recombinant Protein Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Therapeutic Recombinant Protein Market Size by Country (2024-2033) & (US$ Million)
Table 50. Abcam Company Detail
Table 51. Abcam Business Overview
Table 52. Abcam Therapeutic Recombinant Protein Product
Table 53. Abcam Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 54. Abcam Recent Development
Table 55. HALIX Company Detail
Table 56. HALIX Business Overview
Table 57. HALIX Therapeutic Recombinant Protein Product
Table 58. HALIX Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 59. HALIX Recent Development
Table 60. Avantor Company Detail
Table 61. Avantor Business Overview
Table 62. Avantor Therapeutic Recombinant Protein Product
Table 63. Avantor Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 64. Avantor Recent Development
Table 65. Miltenyi Biotec Company Detail
Table 66. Miltenyi Biotec Business Overview
Table 67. Miltenyi Biotec Therapeutic Recombinant Protein Product
Table 68. Miltenyi Biotec Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 69. Miltenyi Biotec Recent Development
Table 70. Thermo Fisher Scientific Company Detail
Table 71. Thermo Fisher Scientific Business Overview
Table 72. Thermo Fisher Scientific Therapeutic Recombinant Protein Product
Table 73. Thermo Fisher Scientific Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 74. Thermo Fisher Scientific Recent Development
Table 75. Bio-Techne Corporation Company Detail
Table 76. Bio-Techne Corporation Business Overview
Table 77. Bio-Techne Corporation Therapeutic Recombinant Protein Product
Table 78. Bio-Techne Corporation Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 79. Bio-Techne Corporation Recent Development
Table 80. Merck Company Detail
Table 81. Merck Business Overview
Table 82. Merck Therapeutic Recombinant Protein Product
Table 83. Merck Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 84. Merck Recent Development
Table 85. ACROBiosystems Company Detail
Table 86. ACROBiosystems Business Overview
Table 87. ACROBiosystems Therapeutic Recombinant Protein Product
Table 88. ACROBiosystems Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 89. ACROBiosystems Recent Development
Table 90. Abnova Company Detail
Table 91. Abnova Business Overview
Table 92. Abnova Therapeutic Recombinant Protein Product
Table 93. Abnova Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 94. Abnova Recent Development
Table 95. Eurogentec (Kaneka Corporation) Company Detail
Table 96. Eurogentec (Kaneka Corporation) Business Overview
Table 97. Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Product
Table 98. Eurogentec (Kaneka Corporation) Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 99. Eurogentec (Kaneka Corporation) Recent Development
Table 100. Cytiva (Danaher ) Company Detail
Table 101. Cytiva (Danaher ) Business Overview
Table 102. Cytiva (Danaher ) Therapeutic Recombinant Protein Product
Table 103. Cytiva (Danaher ) Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 104. Cytiva (Danaher ) Recent Development
Table 105. Reprocell Company Detail
Table 106. Reprocell Business Overview
Table 107. Reprocell Therapeutic Recombinant Protein Product
Table 108. Reprocell Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 109. Reprocell Recent Development
Table 110. GenScript Company Detail
Table 111. GenScript Business Overview
Table 112. GenScript Therapeutic Recombinant Protein Product
Table 113. GenScript Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 114. GenScript Recent Development
Table 115. BPS Bioscience Company Detail
Table 116. BPS Bioscience Business Overview
Table 117. BPS Bioscience Therapeutic Recombinant Protein Product
Table 118. BPS Bioscience Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 119. BPS Bioscience Recent Development
Table 120. Sino Biological Company Detail
Table 121. Sino Biological Business Overview
Table 122. Sino Biological Therapeutic Recombinant Protein Product
Table 123. Sino Biological Revenue in Therapeutic Recombinant Protein Business (2018-2023) & (US$ Million)
Table 124. Sino Biological Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Therapeutic Recombinant Protein Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Therapeutic Recombinant Protein Market Share by Type: 2022 VS 2033
Figure 3. Hormones Features
Figure 4. Blood Clotting Factors Features
Figure 5. Cytokines Features
Figure 6. Enzymes Features
Figure 7. Fusion Proteins Features
Figure 8. Others Features
Figure 9. Global Therapeutic Recombinant Protein Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Therapeutic Recombinant Protein Market Share by Application: 2022 VS 2033
Figure 11. Pharmaceutical Company Case Studies
Figure 12. Research Institute Case Studies
Figure 13. Others Case Studies
Figure 14. Therapeutic Recombinant Protein Report Years Considered
Figure 15. Global Therapeutic Recombinant Protein Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Therapeutic Recombinant Protein Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Therapeutic Recombinant Protein Market Share by Region: 2022 VS 2033
Figure 18. Global Therapeutic Recombinant Protein Market Share by Players in 2022
Figure 19. Global Top Therapeutic Recombinant Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Recombinant Protein as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Therapeutic Recombinant Protein Revenue in 2022
Figure 21. North America Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Therapeutic Recombinant Protein Market Share by Country (2018-2033)
Figure 23. United States Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Therapeutic Recombinant Protein Market Share by Country (2018-2033)
Figure 27. Germany Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Therapeutic Recombinant Protein Market Share by Region (2018-2033)
Figure 35. China Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Therapeutic Recombinant Protein Market Share by Country (2018-2033)
Figure 43. Mexico Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Therapeutic Recombinant Protein Market Share by Country (2018-2033)
Figure 47. Turkey Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Therapeutic Recombinant Protein Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Abcam Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 50. HALIX Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 51. Avantor Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 52. Miltenyi Biotec Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 54. Bio-Techne Corporation Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 55. Merck Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 56. ACROBiosystems Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 57. Abnova Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 58. Eurogentec (Kaneka Corporation) Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 59. Cytiva (Danaher ) Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 60. Reprocell Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 61. GenScript Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 62. BPS Bioscience Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 63. Sino Biological Revenue Growth Rate in Therapeutic Recombinant Protein Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed